1、Table of ContentsUNITED STATESSECURITIES AND EXCHANGE COMMISSIONWashington,D.C.20549FORM 10-Q(Mark One)QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIES EXCHANGE ACTOF 1934 For the quarterly period ended March 31,2025ORTRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d)OF THE SECURITIE
2、S EXCHANGE ACTOF 1934 For the transition period from _ to _Commission File Number:001-38546NEURONETICS,INC.(Exact name of registrant as specified in its charter)Delaware33-1051425(State or other jurisdiction of(I.R.S.Employer Identification No.)incorporation or organization)3222 Phoenixville Pike,Ma
3、lvern,PA19355(Address of principal executive offices)(Zip Code)(610)640-4202(Registrants telephone number,including area code)Not applicable.(Former name,former address and former fiscal year,if changed since last report)Securities registered pursuant to Section 12(b)of the Act:Title of each class T
4、radingSymbol(s)Name on each exchange on which registeredCommon Stock($0.01 par value)STIMThe Nasdaq Global MarketIndicate by check mark whether the registrant(1)has filed all reports required to be filed by Section 13 or 15(d)of theSecurities Exchange Act of 1934 during the preceding 12 months(or fo
5、r such shorter period that the registrant wasrequired to file such reports),and(2)has been subject to such filing requirements for the past 90 days.Yes No Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to besubmitted pursuant to Rule 4
6、05 of Regulation S-T(232.405 of this chapter)during the preceding 12 months(or forsuch shorter period that the registrant was required to submit such files).Yes No Indicate by check mark whether the registrant is a large accelerated filer,an accelerated filer,a non-accelerated filer,asmaller reporti